Sage Journals: Discover world-class research

Retricted access

Review article

First published 2014-2

Combination of Fluticasone Furoate and Vilanterol for the Treatment of Chronic Obstructive Pulmonary Disease

Suzanne G. Bollmeier, Theresa R. Prosser

Annals of Pharmacotherapy

Free access

Research article

First published 2013-12

The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects

Gregory J. Feldman, Anton Edin

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2016-2

The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience

Timothy E. Albertson, John R. Richards, Amir A. Zeki

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2018

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate,umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Mario Malerba, Matteo Nardin, Giuseppe Santini [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2021

The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease

Nawar Diar Bakerly, Dominy Browning, Isabelle Boucot [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized,controlled trial

Francois Maltais, Isabelle Schenkenberger, Pascal L. M. L. Wielders [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2018

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma

Roberto W. Dal Negro, Luca Bonadiman, Paola Turco

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2014-6

Umeclidinium Bromide and Vilanterol Trifenatate Inhalation Powder

Dennis J. Cada, Kyle Ingram, James Leonard [...]

Hospital Pharmacy

Open access

Research article

First published 2023-02

In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler

Melanie Hamilton, Martin Anderson, Rajiv Dhand [...]

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Search results